Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Teligent, Inc. To Present At Morgan Stanley Global Healthcare Conference On September 13, 2016

Posted on: 13 Sep 16

PR Newswire

BUENA, N.J., Sept. 13, 2016

BUENA, N.J., Sept. 13, 2016 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference. The Conference takes place at the Grand Hyatt NY, New York, NY.

Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of Teligent, Inc. will participate in the fireside chat on Tuesday, September 13, 2016 at 3:30 p.m. ET. 

The fireside chat will be webcast and will be accessible online on the investors section of the Company's website at  A replay will be available for 30 days.  

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website


Jenniffer Collins

Teligent, Inc.

(856) 697-4379      

Logo -  


To view the original version on PR Newswire, visit:

SOURCE Teligent, Inc.

PR Newswire

Last updated on: 13/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.